Skip to content

Study on Diabetic Kidney Disease by Multiomics Technology

Study on Diabetic Kidney Disease by Multi-group Science and Technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034438
Enrollment
Unknown
Registered
2020-07-05
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

Healthy control group:None

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the relevant diagnostic criteria of diabetes or diabetic kidney disease and are confirmed; 2. The course of diabetes is more than 1 year; 3. Aged 30 to 80 years; 4. Clear consciousness, no mental retardation, and normal communication; 5. All of them knew about this study and participated voluntarily.

Exclusion criteria

Exclusion criteria: 1) Diabetes should exclude patients with fasting blood glucose < 5.6 mmol L-1, blood glucose < 7.8 mmol L-1 2h after OGTT and transient hyperglycemia caused by other stress factors; 2) Diabetic kidney disease should exclude patients with primary kidney disease; 3) Severe cardiovascular and cerebrovascular, liver and kidney dysfunction; 4) HIV positive, pregnant, cancer, severe infection and malignant tumor patients; 5) Severe mental illness and cognitive dysfunction; 6) Patients diagnosed with type I diabetes or type I diabetic kidney disease; 7) Acute complications of diabetes.

Design outcomes

Primary

MeasureTime frame
Glucose;HbA1c;Triglyceride;Total cholesterol;HDL;LDL;

Countries

China

Contacts

Public ContactYubo Li

Tianjin Unversity of Traditional Chinese Medicine

yaowufenxi001@sina.com+86 15332130770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026